Skip to Content

M 613 (Levetiracetam 250 mg)

Pill with imprint M 613 is White, Round and has been identified as Levetiracetam 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Levetiracetam is used in the treatment of seizures; epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 613

Levetiracetam

Imprint
M 613
Strength
250 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Pyrrolidine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, polydextrose, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-5613 Mylan Pharmaceuticals Inc.
51079-0820 UDL Laboratories Inc.
35356-0429 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "M 613"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.